In 2016, also using the SEER database, Tarantino et al. (9, 27) conducted the two large population-based investigations, which provided compelling evidence that elevated level of preoperative serum CEA was a strong predictor of worse overall and cancer-specific survival in rectal cancer. This evidence concerns the gene CEACAM5 and cancer.